CHRONIC OBSTRUCTIVE PULMONARY DISEASE Measurement of physiological recovery from exacerbation of chronic obstructive pulmonary disease using within-breath forced oscillometry

Background: Within-breath reactance from forced oscillometry estimates resistance via its inspiratory component (Xrs,insp) and flow limitation via its expiratory component (Xrs,exp). Aim: To assess whether reactance can detect recovery from an exacerbation of chronic obstructive pulmonary disease (COPD). Method: 39 subjects with a COPD exacerbation were assessed on three occasions over 6 weeks using postbronchodilator forced oscillometry, arterial blood gases, spirometry including inspiratory capacity, symptoms and health-related quality of life (HRQOL). Results: Significant improvements were seen in all spirometric variables except the ratio of forced expiratory volume in 1 s (FEV1) to vital capacity, ranging in mean (SEM) size from 11.0 (2.2)% predicted for peak expiratory flow to 12.1 (2.3)% predicted for vital capacity at 6 weeks. There was an associated increase in arterial partial pressure of oxygen (PaO2). There were significant mean (SEM) increases in both Xrs,insp and Xrs,exp (27.4 (6.7)% and 37.1 (10.0)%, respectively) but no change in oscillometry resistance (Rrs) values. Symptom scales and HRQOL scores improved. For most variables, the largest improvement occurred within the first week with spirometry having the best signal-to-noise ratio. Changes in symptoms and HRQOL correlated best with changes in FEV1, PaO2 and Xrs,insp. Conclusions: The physiological changes seen following an exacerbation of COPD comprised both an improvement in operating lung volumes and a reduction in airway resistance. Given the ease with which forced oscillometry can be performed in these subjects, measurements of Xrs,insp and Xrs,exp could be useful for tracking recovery.

[1]  J. Cotes,et al.  Determinants of Maximal Flows (Flow Limitation) , 2009 .

[2]  A Pedotti,et al.  Noninvasive detection of expiratory flow limitation in COPD patients during nasal CPAP , 2006, European Respiratory Journal.

[3]  Richard W Costello,et al.  Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.

[4]  S. Aaron,et al.  Physiological changes during symptom recovery from moderate exacerbations of COPD , 2005, European Respiratory Journal.

[5]  R. Stevenson,et al.  Use of reactance to estimate transpulmonary resistance , 2005, European Respiratory Journal.

[6]  S. Spencer,et al.  Impact of preventing exacerbations on deterioration of health status in COPD , 2004, European Respiratory Journal.

[7]  E. Oostveen,et al.  The forced oscillation technique in clinical practice: methodology, recommendations and future developments , 2003, European Respiratory Journal.

[8]  S. Spencer,et al.  Time course of recovery of health status following an infective exacerbation of chronic bronchitis , 2003, Thorax.

[9]  R. Stockley,et al.  Symptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitis , 2001, Thorax.

[10]  P. Jones,et al.  Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL). , 2000, Respiratory medicine.

[11]  T. Seemungal,et al.  Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[12]  L. Davies,et al.  Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial , 1999, The Lancet.

[13]  D. O’Donnell,et al.  Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[14]  P. Paggiaro,et al.  Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease , 1998, The Lancet.

[15]  BTS Guidelines for the Management of Chronic Obstructive Pulmonary Disease , 1997, Thorax.

[16]  M. Silverman,et al.  Comparison of four methods of assessing airflow resistance before and after induced airway narrowing in normal subjects. , 1995, Journal of applied physiology.

[17]  C. Roberts,et al.  Arterialised earlobe blood gas analysis: an underused technique. , 1994, Thorax.

[18]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[19]  P. Jones,et al.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.

[20]  C. Wells,et al.  The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. , 1984, Chest.

[21]  F. Primiano,et al.  Computation of respiratory impedance from forced sinusoidal oscillations during breathing. , 1983, Computers and biomedical research, an international journal.

[22]  M. Artvinli,et al.  Dyspnoea, disability and distance walked: Comparison of estimates of exercise performance in respiratory disease , 1980, International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation.

[23]  E D Michaelson,et al.  Pulmonary mechanics by spectral analysis of forced random noise. , 1975, The Journal of clinical investigation.

[24]  A Pedotti,et al.  Detection of expiratory flow limitation in COPD using the forced oscillation technique , 2004, European Respiratory Journal.

[25]  D. Niewoehner,et al.  Relation of FEV(1) to clinical outcomes during exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. , 2000, American journal of respiratory and critical care medicine.

[26]  W. MacNee,et al.  Randomized controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease. , 2000, Thorax.

[27]  BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. , 1997, Thorax.

[28]  Guidelines for the measurement of respiratory function. Recommendations of the British Thoracic Society and the Association of Respiratory Technicians and Physiologists. , 1994, Respiratory medicine.

[29]  G. Borg Psychophysical bases of perceived exertion. , 1982, Medicine and science in sports and exercise.